ES
Eric E. Schadt

Elite Scholar

762
Works
89,489
Citations
135
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Eric E. Schadt

Also known as: E E Schadt, E SCHADT, E Schadt, E. E. Schadt, E. Schadt

762

Total Works

89,489

Citations

135

H-Index

415

i10-Index

Citation & Works Trend by Year
28 years active
Top Research Topics
Genetic Associations and Epidemiology (190) Bioinformatics and Genomic Networks (129) Cancer Immunotherapy and Biomarkers (103) Genetic Mapping and Diversity in Plants and Animals (82) Cancer Genomics and Diagnostics (59)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Plasma proteins are integral to cross-tissue gene regulatory networks implicated in cardiometabolic disorders and coronary artery disease Cell Systems 0
2026 Correction: Mutational patterns in a large cohort of parathyroid carcinomas Journal of Endocrinological Investigation 0
2026 Protocol for classifying cellular senescence from single-cell and single-nucleus RNA sequencing data STAR Protocols 0
2026 Supp Fig7+ Legend from PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting 0
2026 Supp Fig6+ Legend from PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting 0
2026 Supplementary Table3 from PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting 0
2026 Supplementary Table2 from PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting 0
2026 Supplementary Table1. from PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting 0
2026 Supp Fig4+ Legend from PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting 0
2026 Supp Fig3 + Legend from PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting 0
2026 Supplementary Table5 from PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting 0
2026 Supp Fig2 + Legend from PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting 0
2026 Supp Fig1+ Legend from PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting 0
2026 Supp Fig5+ Legend from PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting 0
2026 Supplementary Table4 from PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting 0

Data source: OpenAlex API